A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00148369|
Recruitment Status : Completed
First Posted : September 8, 2005
Last Update Posted : February 19, 2010
|Condition or disease||Intervention/treatment|
|Idiopathic Parkinson's Disease||Drug: Safety observation|
|Study Type :||Observational|
|Actual Enrollment :||31 participants|
|Official Title:||A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin|
|Study Start Date :||June 2005|
|Actual Primary Completion Date :||November 2006|
|Actual Study Completion Date :||September 2007|
Subjects previously administered GDNF and have discontinued the drug.
Drug: Safety observation
Subjects previously enrolled in a GDNF protocol observed for 2 years after discontinuation of drug.
- Adverse Events [ Time Frame: 24 months ]
Biospecimen Retention: None Retained
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00148369